Cytotoxic Effects of Apiin

Yıl 2021, , 64 - 70, 30.12.2021

A. Cansu Kilit , Demir Aydemir

https://doi.org/10.37215/bilar.952454

Cited By: 1

Öz

Cancer is the most deadly disease of our age. Existing drugs used for cancer treatment are insufficient in the treatment of cancer due to cumulative mutations. Therefore, there is a need for studies to discover new molecules or to increase drug efficacy in cancer treatment. In terms of the design of new anticancer drugs, the relationship of herbal-derived agents with cancer stands out. It is known that flavonoids taken in our daily diet, together with other components such as various vitamins, play an important role in the prevention of cancer. Flavonoids are thermostable polyphenolic compounds commonly found in nature. Apigenin is an important component of the human diet, such as many fruits and vegetables represented by chamomile, celery and parsley, and it has been shown in various studies to have antitimetastatic and antitumoral effects in many cancers. In our study, Apiin flavonoid belonging to the Apigenin family was tested for the first time on cancer cell lines such as MDAMB231, MCF-7, 293T, 22RV1, U87 at doses of 200, 100, 50 and 25 μg/mL for 24 short-term periods and whether it showed cytotoxic effects.It was observed that Apiin showed selective cytotoxicity in the aforementioned cancer cells. We hope that this study will shed light on other studies on investigating the mechanism of death of Apiin in more detail and as an alternative treatment to cancer treatments.

Anahtar Kelimeler

Cancer, phenolic compounds, apiin, cytotoxicity

Apiin’in Sitotoksik Etkisi

Öz

Kanser, çağımızın en çok ölümle sonuçlanan hastalığıdır. Kanser tedavisinde kullanılmakta olan ilaçlar, birikerek çoğalan mutasyonlardan dolayı kansere karşı tedavide yetersiz kalmaktadır. Bu nedenle kanser tedavisinde yeni molekülleri keşfetmeye veya ilaç etkinliğini artırmaya yönelik yapılan çalışmalara ihtiyaç duyulmaktadır. Yeni antikanser ilaçların tasarımı bakımınkdan bitkisel türevli ajanların kanserle olan ilişkileri göze çarpmaktadır. Beslenmeyle günlük diyetimizde alınan flavonoidlerin, çeşitli vitaminler gibi diğer bileşenlerle birlikte, kanserin önlenmesinde önemli bir rol oynadığı bilinmektedir. Flavonoidler, doğada yaygın olarak bulunan, ısıya dayanıklı polifenolik bileşiklerdir. Apigenin, papatya, kereviz ve maydanoz ile temsil edilen çok sayıda meyve, sebze gibi insan diyetinin önemli bir bileşenidir ve birçok kanserde antimetastatik ve antitümöral etkilerinin olduğu çeşitli çalışmalarla gösterilmiştir. Çalışmamızda Apigenin ailesine ait olan Apiin flavonoidi ilk kez MDAMB231, MCF-7, 293T, 22RV1, U87 gibi kanser hücre hatları üzerinde 200, 100, 50 ve 25 μg/mL dozlarda 24 saatlik inkübasyon süresinde denenmiş olup, sitotoksik etki gösterip göstermediği test edilmiştir. Apiin’in bahsi geçen kanser hücrelerinde seçici sitotoksisite gösterdiği gözlemlenmiştir. Bu çalışmanın Apiin’in daha ayrıntılı ölüm
mekanizmasının araştırılması ve kanser tedavilerine alternatif tedavi olabilmesi konusunda diğer çalışmalara ışık tutacağını umut etmekteyiz.

Anahtar Kelimeler

Kanser, fenolik bileşikler, apiin, sitotoksisite

Kaynakça

• Beutler, J.A., Hamel, E., Vlietinck, A.J., Haemers, A., Rajan, P., Roitman, J. (1998). “Structure–activity requirements for flavone cytotoxicity and binding to tubulin”. J Med Chem, 41: 2333–8.
• Cook, N.C., Samman, S. (1996). “Flavonoids-Chemistry, metabolism, cardioprotective effects and dietary sources”. The Journal of Nutritional Biochemistry, 7(2): 66-76.
• Da Rocha, A.B., Lopez, R.M., Schwartsmann, G. (2001). “Natural products in anticancet therapy”. Curr Opin in Pharmacol, 1:364-69.
• Galati, G., Teng, S., Moridani, M.Y., Chan, T.S., O’Brien, P.J. (2000). “Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics”. Drug Metabol Drug Interact 17: 311-49.
• Ghitu, A., Schwiebs, A.,. Radeke, H.H., Avram, S.,1, Zupko I., Bor, A., Pavel I.Z., Dehelean, C.A., Oprean, C., Bojin, F.,
• Farcas, C., Soica, C., Duicu, O. and Danciu, C. (2019). “A Comprehensive Assessment of Apigenin as an Antiproliferative, Proapoptotic, Antiangiogenic and Immunomodulatory Phytocompound”. Nutrients, 11: 858.
• González-Gallego, J., García-Mediavilla, V.M., Sánchez-Campos, S., Tuñón, J.M. (2010). “Fruit polyphenols, immunity and inflammation”. Brit J Nut, 104:15-27.
• Gryglewski, R.J., Korbut R., Robak J., Swies J. (1987). “On the mechanism of antithrombotic action of flavonoids”. Biochemical Pharmacology, 36(3): 317-322.
• Hanahan, D., Weinberg, R.A., Hanahan, P.D. (2017) “Biological hallmarks of cancer”. Holland Frei Cancer Med, 646–74.
• Harrington, K.J. (2016). “The biology of cancer”. Cancer Biol Imag, 44(1): 1-5.
• Hollman, P.C., Katan, M.B. (1999). “Dietary flavonoids: Intake, health effects and bioavailability”. Food Chem Toxicol, 37: 937–942.
• Hwang, Y.P., Oh, K.N., Yun, H.J., Jeong, H.G. (2011). “The flavonoids apigenin and luteolin suppress ultraviolet Ainduced matrix metalloproteinase-1 expression via MAPKs and AP-1- dependent signaling in HaCaT cells”. J Dermatol Sci., 61(1): 23–31.
• Karakaya, S., El, S.N. (1997). “Flavonoidler Ve Sağlık Beslenme ve Diyet”. J Nutr and Diet, 26(2): 54-60.
• Kazuo, Y., Yukio, Y. (2020). “Inhibition of Endothelial Dysfunction by Dietary Flavonoids and Preventive Effects Against Cardiovascular Disease”. J Cardiovasc Pharm, 75: 1-9.
• Khazir, J., Mir, B.A., Pilcher, L., Riley, D.L. (2014). “Role of plants in anticancer drug discovery”. Phytochem Lett, 7: 173-81 .
• Kilit, A.C., Aydemir, E., Fiskin, K. (2020). “Combination of endostatin and vinoralbine enhances control of breast cancer cells while endostatin ameliorates the toxicity of vinoralbine in nor mal cells”. Genetic Molecular Reserch, 19(1): 18497
• Kuntz, S., Wenzel, U., Daniel, H. (1999). “Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines”. Eur J Nutr, 38: 133- 42.
• Li Y, Yang B, Bai J-Y, Xia S, Mao M, Li X, Li N, Chen L. (2019). “The roles of synovial hyperplasia, angiogenesis and osteoclastogenesis in the protective effect of apigenin on collagen-induced arthritis”. Int Immunopharmacol, 73:362–9.
• Li, Y., Chen, X., He, W., Xia, S., Jiang, X., Li, X., Bai, J., Li, N., Chen, L. Yang, B. (2020). “Apigenin Enhanced Antitumor Effect of Cisplatin in Lung Cancer via Inhibition of Cancer Stem Cells”. Nutrition and Cancer, https://doi.org/10.1080/01635581.2020.1802494
• Lindenmeyer, F., Li, H., Menashi, S., Soria, C., Lu, H. (2001). “Apigenin acts on the tumor cell invasion process and regulates protease production.” Nutr Cancer. 39(1): 139–47.
• Middleton, E., Kandaswami, C., Theoharides, T.C. (2000). “The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer”. Pharmacol Rev, 52,673-751.
• Mirzoeva, S., Kim, N.D., Chiu, K., Franzen, C.A., Bergan, R.C., Pelling J.C. (2008) “Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells”. Mol Carcinog. 47(9): 686–700.
• Mishra, B.B., Tiwari, V.K. (2011). “Natural products: An evolving role in future drug discovery”. Eur J Med Chem, 46: 4769-4807.
• Mojzisa, J., Varinskaa, L., Mojzisova, G., Kostovac, I., Mirossaya, L. (2008) “Anti-angiogenic effects of flavonoids and chalcones”. Pharmacol Res, 57: 259–65.
• Ouyang, L., Shi, Z., Zhao, S., Wang, F.T., Zhou, T.T., Liu, B., Bao, J.K. (2012). “Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis”. Cell Prolif, 45(6): 487-498.
• Petti, S., Scully, C. (2009). “Polyphenols, oral health and disease: A review”. J Dent, 37(6): 413-423.
• Ravishankar, D., Rajora, A.K., Greco, F., Osborn, H.M.I. (2013). “Flavonoids as prospective compounds for anti-cancer therapy”. J Biochem & Cell Bio, 45: 2821-31.
• Saklani, A., Kutty, S.K. (2008). “Plant-derived compounds in clinical trials”. Drug Discov Today Biosilico, 13 (3/4): 161-71.
• Shmuel, Y. (2004). “Dictionary of food compounds with CDROM: Additives, flavors, and ingredients”. Boca Raton: Chapman & Hall/CRC.
• Yang, C.S., Landau, J.M., Huang, M.T. (2001). “Newmark HL. Inhibition of carcinogenesis by dietary polyphenolic compounds”. Annu Rev Nutr, 21: 381-406.
• Yao, L.H, Jiang, Y.M., Shi, J., Tomás-Barberán, F.A., Datta, H., Singanusong, R. (2004). “Flavonoids in food and their health benefits”. Plant Food Hum Nutr, 59: 113-22.